IN BRIEF: Huge Actos Award

The National Law Journal

   | 0 Comments

A jury in Louisiana awarded more than $9 billion in the first federal bellwether trial over claims that taking diabetes drug Actos increases the risk of bladder cancer. Plus more from NLJ.com and other ALM publications.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202650835197

Thank you!

This article's comments will be reviewed.